HEMATOPOIETIC STEM CELL TRANSPLANTATION IN SOUTHERN IRAN: HISTORY, CURRENT STATUS AND FUTURE DIRECTION

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

RAMZI M.

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: Iranian Red Crescent Medical Journal Year:2009 | Volume:11 | Issue:4 Page(s): 364-370

Download Full-Text

View:

404

Download:

233

Cites:

Information Journal Paper

Title

HEMATOPOIETIC STEM CELL TRANSPLANTATION IN SOUTHERN IRAN: HISTORY, CURRENT STATUS AND FUTURE DIRECTION

Author(s)

RAMZI M. | Issue Writer Certificate

Keywords

STEM CELL

TRANSPLANTATION

HEMATOPOIETIC

THALASSEMIA MAJOR

HEMATOLOGIC MALIGNANCY

IRAN

Abstract

Transplantation of HEMATOPOIETIC STEM CELLs (HSCT) has become the standard treatment for many patients with congenital or acquired disorders of the HEMATOPOIETIC system or with chemo-radio or immuno-sensitive malignancies. HSCT has undergone rapid expansion over the past two decades. Despite the high cost and the complexity of the procedure, HSCT has developed in developing countries. The transplant program was established in Shiraz University of Medical Sciences in 1993 in Shiraz, southern IRAN and is a referral center for about 10 million patients with hematology-oncology diseases. From 1993 to 2009, more than 450 allogeneic and autologous TRANSPLANTATIONs were undertaken. Since 2003, STEM CELL sources from the bone marrow have changed to peripheral blood for almost all disease indications. The main indication for HSCT is now the hematologic malignancies instead of hemoglobinopathy (thalassemia major). From 1993 to 2007, HSCT was performed on 155 blood transfusion dependent patients with THALASSEMIA MAJOR with disease-free survival and overall survival of 71% and 77%, respectively. During this time, 127 leukemia patients underwent allogeneic HSCT including AML (n=68), ALL (n=30) and CML (n=29). In this group, long term disease-free survival rate (cure rate) was 67%, 60% and 62%, respectively. Even HSCT is rising rapidly in during the five past years; however, when the total TRANSPLANTATION to the total number of population is compared in our region, the rate is still low. It seems that the government should support the therapeutic approaches more in our country and help to overcome the difficulties.

Cites

No record.

References

Cite

APA: Copy

RAMZI, M.. (2009). HEMATOPOIETIC STEM CELL TRANSPLANTATION IN SOUTHERN IRAN: HISTORY, CURRENT STATUS AND FUTURE DIRECTION. IRANIAN RED CRESCENT MEDICAL JOURNAL (IRCMJ), 11(4), 364-370. SID. https://sid.ir/paper/292159/en

Vancouver: Copy

RAMZI M.. HEMATOPOIETIC STEM CELL TRANSPLANTATION IN SOUTHERN IRAN: HISTORY, CURRENT STATUS AND FUTURE DIRECTION. IRANIAN RED CRESCENT MEDICAL JOURNAL (IRCMJ)[Internet]. 2009;11(4):364-370. Available from: https://sid.ir/paper/292159/en

IEEE: Copy

M. RAMZI, “HEMATOPOIETIC STEM CELL TRANSPLANTATION IN SOUTHERN IRAN: HISTORY, CURRENT STATUS AND FUTURE DIRECTION,” IRANIAN RED CRESCENT MEDICAL JOURNAL (IRCMJ), vol. 11, no. 4, pp. 364–370, 2009, [Online]. Available: https://sid.ir/paper/292159/en

Related Journal Papers

No record.

Related Seminar Papers

No record.

Related Plans

No record.

Recommended Workshops